"Sentara Vascular Specialists - The quality vascular and transplant surgeons of Sentara Vascular Specialists offer comprehensive vascular and transplant services for all disorders involving the circulatory system, peripheral arteries and veins. In-office non-invasive vascular testing is available, and our vascular surgeons provide the most advanced techniques in diagnostic angiography, vascular surgery, endovascular interventions, vascular access for chemotherapy and kidney dialysis, and the removal of varicose veins. We also have the Sentara Renal Transplant Unit, enabling our physicians to better meet the needs of renal failure patients with our active transplantation services."

During the past decade, Sentara Vascular Specialists conducted 14 clinical trials. In the 10-year time frame, 14 clinical trials started and 16 clinical trials were completed, i.e. on average, 114.3% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 11 clinical trials were completed. i.e. 366.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Sentara Vascular Specialists" #1 sponsor was "Boston Scientific Corporation" with 2 trials, followed by "Cook Research Incorporated" with 2 trials sponsored, "Endologix" with 2 trials sponsored, "Medtronic Cardiovascular" with 2 trials sponsored and "Medtronic Endovascular" with 2 trials sponsored. Other sponsors include 11 different institutions and companies that sponsored additional 18 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Sentara Vascular Specialists" #1 collaborator was "Massachusetts General Hospital" with 2 trials as a collaborator, "Medtronic" with 2 trials as a collaborator, "Abbott" with 1 trials as a collaborator, "BTG International Inc." with 1 trials as a collaborator and "Bard Ltd" with 1 trials as a collaborator. Other collaborators include 17 different institutions and companies that were collaborators in the rest 27 trials.

According to Clinical.Site data, the most researched conditions in "Sentara Vascular Specialists" are "Peripheral Artery Disease" (3 trials), "Abdominal Aortic Aneurysm" (2 trials), "Arteriovenous Fistula" (2 trials), "Critical Limb Ischemia" (2 trials) and "Peripheral Arterial Disease" (2 trials). Many other conditions were trialed in "Sentara Vascular Specialists" in a lesser frequency.

Most popular intervention types in "Sentara Vascular Specialists" are "Device" (22 trials), "Biological" (2 trials), "Drug" (2 trials), "Other" (2 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "Indigo Aspiration System" (2 trials), "Participating Site's standard practice" (2 trials), "SRM003" (2 trials), "Tack Endovascular System" (2 trials) and "AFX EVAR AAA Graft System" (1 trials). Other intervention names were less common.

The vast majority of trials in "Sentara Vascular Specialists" are 26 trials for "All" genders.

Currently, there are NaN active trials in "Sentara Vascular Specialists". undefined are not yet recruiting, 1 are recruiting, 6 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 17 completed trials in Sentara Vascular Specialists, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Sentara Vascular Specialists, 1 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 17 trials that are defined as “Not Applicable".